Positive results from early trial of drug that could protect brain cells
Date
Research news
Date
A partnership involving Parkinson’s UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
Date
We're providing £2.1million through our Virtual Biotech programme to develop a potential new drug which holds promise for protecting brain cells in Parkinson's.
Date
The TOP HAT trial is closing early and we have an important update on next steps.
Date
Parkinson’s UK has funded two future leaders in Parkinson’s research who are pushing forward our understanding of the early stages and causes of Parkinson’s.
Date
Early research shows transplanting gut bacteria from healthy individuals to people with Parkinson’s, called a faecal microbiota transplant, is safe and may ease motor symptoms.
Date
Lixisenatide, a diabetes drug being investigated for Parkinson’s, shows potential to slow the progression of movement symptoms.
Date
New research study shows impact of delirium for people with Parkinson’s in hospital
Date
The simple skin test was able to detect a troublesome protein associated with Parkinson's and other similar conditions.
Date
Our latest round of grants fund projects which aim to improve everyday life for people living with Parkinson’s, without the need for extra medications.
Date
A further trial of a device-delivered GDNF is not going ahead, but other approaches are showing promise.